EPHX2 encodes a cytosolic epoxide hydrolase, and its depletion in various cancers may induce aberrant expression, resulting in metabolic dysfunctions that could influence cancer progression and metastasis differently depending on the stage of cancer development [45]. The gene discussed is EPHX2; the disease is cancer.